Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Profit After Tax: 2011-2024

Historic Profit After Tax for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $8.6 million.

  • Niagen Bioscience's Profit After Tax rose 143.77% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.5 million, marking a year-over-year increase of 1281.55%. This contributed to the annual value of $8.6 million for FY2024, which is 274.16% up from last year.
  • According to the latest figures from FY2024, Niagen Bioscience's Profit After Tax is $8.6 million, which was up 274.16% from -$4.9 million recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Profit After Tax registered a high of $8.6 million during FY2024, and its lowest value of -$27.1 million during FY2021.
  • Its 3-year average for Profit After Tax is -$4.3 million, with a median of -$4.9 million in 2023.
  • Its Profit After Tax has fluctuated over the past 5 years, first slumped by 36.15% in 2021, then spiked by 274.16% in 2024.
  • Niagen Bioscience's Profit After Tax (Yearly) stood at -$19.9 million in 2020, then plummeted by 36.15% to -$27.1 million in 2021, then surged by 39.03% to -$16.5 million in 2022, then soared by 70.15% to -$4.9 million in 2023, then soared by 274.16% to $8.6 million in 2024.